The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2U INC COM 90214J101 40,450 2,594,620 SH   DFND 1 2,594,620 0 0
OVASCIENCE INC COM 69014Q101 38,494 2,318,940 SH   DFND 1 2,318,940 0 0
CERULEAN PHARMA INC COM 15708Q105 633 166,675 SH   DFND 1 166,675 0 0
VERASTEM INC COM 92337C104 10,142 1,190,358 SH   DFND 1 1,190,358 0 0
WIX COM LTD SHS M98068105 128,960 7,935,978 SH   DFND 1 7,935,978 0 0
TWITTER INC COM 90184L102 479 10,326 SH   DFND 1 10,326 0 0
ACCELERON PHARMA INC COM 00434H108 5,294 175,075 SH   DFND 1 175,075 0 0